Maggie is an editor for The American Journal of Managed Care® (AJMC®) and produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.
She has a BA in English from Penn State University. You can connect with Maggie on LinkedIn.
Clinical Surveillance Remains Necessary Among Cladribine-Treated Patients With RRMS
April 13th 2021A prospective bicentric cohort study among individuals with relapsing-remitting multiple sclerosis (RRMS) showed that 32% developed at least 1 skin-related adverse reaction following cladribine administration.
Read More
More Research Needed on Possible Link Between Hot Flashes, CVD in Women With HIV
April 12th 2021Previous studies have investigated the association between hot flashes and immune system activation among women with HIV, but this is the first study to investigate an additional link to adverse subclinical cardiac pathology.
Read More
Pricing, Payment Reform, and Politics Are Inextricably Linked in Cancer Care
April 9th 2021On day 2 of this year’s Community Oncology Conference, a panel of government and health policy experts gathered to discuss the hot-button issue of political influence on cancer policy and the damage community oncology has suffered this past year.
Read More
Patients Are the “Value” Focus in Cancer Care, Panelists Agree
April 9th 2021There are many sources, and definitions, of where the value in cancer care lies. In this panel discussion, a cancer survivor and patient advocate, an oncologist, and a benefits professional provided their perspectives on what value in cancer care means to them.
Read More
Palliative Care Encompasses Much More Than End-of-Life Care
April 8th 2021A popular misconception of palliative care is that it only has importance toward making patients comfortable at the end of their lives, noted a palliative care physician on the first day of the 2021 Community Oncology Conference, presented by the Community Oncology Alliance.
Read More
CeSHHAR Working to Improve HIV Service Uptake, Self-testing in Zimbabwe
March 30th 2021This feature is the first in a 6-part series on individuals and international organizations working to bring local and global awareness to the ongoing HIV/AIDS epidemic, which is marking its 40th anniversary this year.
Read More
Transcranial Direct Current Stimulation May Benefit Patients With MS
March 30th 2021With most current therapies for patients with multiple sclerosis (MS) targeting disease progression, a recent review evaluated transcranial direct current stimulation’s ability to improve certain disease symptoms.
Read More
KCCQ-OS Better Able to Predict Changes in Health Status, Study Says
March 25th 2021After a 12-month follow-up of patients in the CHAMP-HF registry, Kansas City Cardiomyopathy Questionnaire Overall Summary Score (KCCQ-OS) was shown to be more prognostically accurate compared with New York Heart Association functional class.
Read More
Review Recommends Guidelines for Patients With MS Taking Herbal Drugs, Supplements
March 24th 2021With many patients with multiple sclerosis (MS) increasingly turning to herbal drugs and supplements to treat their disease, for which there is no cure, a recent review evaluated the safety of these alternative therapies.
Read More
Risk Factors Identified That Predispose Patients With MS, COVID-19 to Worse Outcomes
March 19th 2021Among these factors, having a higher degree of disability from multiple sclerosis (MS) was independently associated with higher morbidity and mortality risks from having a comorbid case of COVID-19.
Read More
Timely ART Initiation Varies Among Persons Who Have HIV, Study Finds
March 18th 2021Despite HHS’ recommendation that everyone with HIV start antiretroviral therapy (ART) soon after their diagnosis, uptick disparities remain and are especially apparent among persons with drug abuse or dependence.
Read More
Infection Risk, Medical Claims High Among Patients With Multiple Sclerosis
March 17th 2021Patients with multiple sclerosis have high rates of urinary and kidney infections, inpatient hospitalizations, and outpatient hospital claims, according to recent results presented at the Americas Committee for Treatment and Research in Multiple Sclerosis annual meeting.
Read More
Lenacapavir Against HIV Demonstrates Ongoing Potential
March 16th 2021The safety and effectiveness of the long-acting agent is backed by data from trials of the drug among treatment-experienced individuals living with HIV-1 whose viral load is on the rise due to other regimens failing. Investigation continues among these patients, as well as treatment-naive patients.
Read More